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Original Article
Redo coronary artery surgery; early and intermediate outcomes
from a tertiary care hospital in a developing country
Syed Shahabuddin, Junaid Alam Ansari, Fahad Jawaid Siddiqui, Muneer Amanullah, Shahid Ahmed Sami
Cardiothoracic Surgery Section, Department of Surgery, The Aga Khan University, Karachi, Pakistan.
Abstract
Objective: To evaluate outcomes of re-operative coronary artery surgery in a tertiary care hospital in a developing country.
Method: Preoperative, intra-operative and postoperative variables were analyzed in 82 consecutive patients
who underwent re-operative coronary surgery on cardiopulmonary bypass.
Results: The mean age was 63.3 ± 7.7 years, 91.2% were male and 9.8% female. Coronary artery disease risk
factors were present in more than 50% of the patients. History of preoperative myocardial infarction was positive
in 56% patients. There was strong clinical and angiographic indication for surgery with unstable angina in 50%
patients and >80% had multivessel disease. Only 5% patients were in functional class I. The risk stratification
showed a mean Euro score of 8. The IABP was used in 20% patients. A mean of 3.1 grafts per patient were
applied. The median cardiopulmonary bypass (CPB) and aortic cross clamp time was 144 minutes respectively.
Postoperative mortality was 7.3%. Short term follow up revealed 74% of the patients in NYHA functional class I.
Conclusion: Reoperative coronary artery bypass grafting is challenging but with expertise, team effort can be
performed with good functional outcome.
Keywors: Redo CABG, Developing country, outcomes (JPMA 61:31; 2011).
Introduction
It has been estimated that 10-20% of all patients who
have had aorto-coronary bypass will require a second bypass
procedure within 10 years.1 Coronary re-operations are
demanding procedures especially with an increased risk
profile of these patients.2 Coronary artery disease (CAD)
progresses with time involving native vessels, both grafted
and non-grafted, and the vein grafts.3 These patients may
require management of their symptoms from recurrence of
CAD. These patients may require surgical intervention. Redo
CABG is a major surgical procedure with a high mortality of
up to 11.4%.4 Despite alternative strategies in the
management of recurrent angina following coronary artery
bypass grafting (CABG) the conventional re-operative
coronary surgery on cardiopulmonary bypass (CPB) remains
the standard surgical technique for complete
revascularization in multi-vessel disease. Redo CABG with
re-sternotomy carries a potential risk of catastrophic
bleeding5 damage to previous patent grafts and
thromoboembolism from diseased grafts leading to peri-
operative myocardial infarction (MI) and CVA. These are the
commonest factors contributing to postoperative mortality.6
In view of the above issues, we looked at the 30 day and late
mortality along with their functional class at follow up in
patients undergoing redo CABG.
Patients and Methods
Using the computerized database, all patients who
underwent redo CABG from 1997 to 2007 were selected for
the study at the Aga Khan University Hospital. All off pump
redo CABG, or those operated using left thoracotomy with
beating heart on CPB were excluded to ensure that the study
group remains homogenous. The medical records were
retrieved, reviewed and the pre-operative, intra-operative and
post-operative variables were entered into a specifically
developed dataset. Variables considered were indication for
surgery, severity of disease, comorbidities, Euro SCORE,
priority of admission, and type of surgery. Renal failure was
defined as serum creatinine >1.5 mg/dl. Prolonged ventilation
was defined as mechanical ventilation for >24 hours. Left
ventricular (LV) dysfunction was categorized on the basis of
ejection fraction and considered severe, moderate, mild, or
normal if ejection fraction was < 35%, 35 to < 45%, 45 to <
55%, or 55% and above, respectively. Perioperative variables
included the use of an intra-aortic balloon pump, type of
previous graft, and duration of surgery. The operative aspects
recorded were number of grafts, the use of internal mammary
artery (IMA), and duration of cardiopulmonary bypass and
cross clamp time. The indications for intra-aortic balloon
pumping (IABP) were unstable angina, cardiogenic shock,
low cardiac output and inability to wean patient from CPB.
Postoperative characteristics were focused on outcomes
including length of stay, complications, 30 day mortality,
assessment of New York Heart Association (NYHA)
functional class on follow up and late death. Functional class
improvement was assessed at follow-up and by telephone
questionnaire.
Frequencies were reported for categorical variables.
Skewed data was likely due to nature of the variables
recorded on continuous scale. Hence median and inter
quartile ranges were reported unless otherwise indicated.
Kaplan Meier survival curve was plotted for survival data.
The standard operating strategies for redo CABG was
to have blood and cell saver device with cutaneous pads for
defibrillation/pacing attached. Femoral artery was either
marked or exposed once the patient was induced. A redo
median sternotomy was performed using an oscillating saw.
Sharp dissection was done to mobilize the heart away from
the sternum. The right atrium and aorta were exposed to
facilitate aorto caval cannulation after systemic
heparinisation (300units/kg). Cardiopulmonary bypass was
commenced urgently in the presence of ischaemic ECG
changes, injury to patent grafts, haemodynamic instability
and also to ease technically difficult dissection. Most of the
patients were put on cardiopulmonary bypass through central
cannulation. However in few cases CPB was established
using femoral vascular access. Myocardial protection was
achieved by administration of blood cardioplegia by
antegrade and retrograde routes. Moderate hypothermia
(28ºC to 32ºC) with topical cooling was used to enhance
myocardial protection. Previous vein grafts were interrupted
by ligation and wherever internal mammary graft was patent,
efforts were made to preserve the graft and careful isolation
was done for temporary occlusion of IMA during cross clamp
period. Distal anastomoses were constructed on an arrested
heart. During the rewarming phase the proximal ends of the
vein grafts were anastomosed to the aorta using either a single
clamp technique or partial occlusion of ascending aorta
depending upon the condition of the aortic wall. After the
heart had reperfused CPB was weaning usually with inotropic
support, and the sternum was closed. 
Result
From January, 1997 to December 2007, 91 patients
were identified to have undergone redo CABG at Aga Khan
University Hospital. Out of these 8 were off pump cases and
1 patient was operated through an anterolateral thoracotomy,
hence 9 patients were excluded.
The preoperative characteristics of 82 eligible
patients are shown in Table-1. All the patients were
symptomatic and more than 87% of them were in NYHA
class II or III. Angiography revealed multivessel CAD in
90% cases, while 60% had some degree of impaired left
ventricular function. 
The mean age was 63.3 ± 7.7 years with 8 (9.8%)
patients being female. Coronary artery disease risk factors
including tobacco use status (current, previous or non-user),
dyslipidaemia and family history were present in more than
50% patients (Table-1). Previous myocardial infarction was
experienced by 46 (56%) patients. Clinical and angiographic
indication for surgery were; unstable angina in 42 (50%)
patients and >80% had multivessel disease. These patients
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were operated after few months to more than ten years of
primary CABG. Only 4 (5%) patients were in functional class
I preoperatively. The risk stratification using Euro SCORE
was a mean of 8. IABP was used in 20% patients. A mean of
3.1 grafts per patient were applied. The median CPB and
aortic cross clamp times were 144 minutes and 82 minutes,
respectively. Most frequently observed complication was
prolonged ventilation, 15 (30%) followed by renal failure,
atrial fibrillation and bleeding in 2 (3.2%) patients.
Postoperative mortality was 7.3%. The surviving patients
were followed up for a median period of 3.5 years. A further
5 (6.1%) patients died on follow up (late mortality). On late
follow up 74% of the patients were in functional class I. A
further analysis of surviving patients revealed 5 year survival
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Table-1: Patient characteristics.
Characteristics Mean/n SD %
Age at surgery (years) 63.3 ± 7.7
Gender (Males) 74 (90.2%)
Positive family history 44 (53.7%)
Smoking
Current 10 ± 12.2
Ex-smoker 36 ± 43.9
Non-smoker 36 ± 43.9
BMI (add cut offs)
Normal weight 30 ± 36.6
Overweight 43 ± 52.4
Obese 9 ± 11.0
NYHA Class
I 4 ± 4.9
II 34 ± 41.5
III 30 ± 36.6
IV 14 ± 17.1
Previous MI
Yes 46 ± 56.1
No 36 ± 43.9
Time since first CABG (Years) 12.3 ± 5.9
< 1 year 2 ± 2.4
> 1 year - <5 years 6 ± 7.3
> 5 year - < 10 years 20 ± 24.4
> 10 years - <15 years 25 ± 30.5
> 15 years 29 ± 35.4
EuroScore* 8.1 ± 4.8-17.3
*Median (IQR)
Table-2: Review of survival studies.
Study reference Studied period Number Described Survival (/ %)
of patients - mean age mortality 5 years 10 years
Salomon et al.15 1970–1988 30 days: 6.9% 80 65
508 patients–59 years
Lyttle et al.16 1967–1984 Hospital: ±3.4% 90 75
1500 patients–±56 years
Yamarmuro et al.17 1983–1993 Hospital: 7.6% 75 49
739 patients (>70 years)– 74 years
Shapira et al.18 1978–1989 30 days: 3% 90 74
498 patients–64.6 years
Loop et al.19 1967–1987 Hospital±3% 63.4
2500 patients–±57 years
Blanche et al20 1983–1996 Hospital: 8% 58
49 patients >80–82 years
Weintraub et al.[I]†21 1975–1993 Hospital: 7% 76 55
2030 patients–61 years
Weintraub et al. [II]†22 779 patients–60–69 years Hospital: 8.2% 73 40
Noyez et al.*13 1987–1992 Hospital: 6.7% 76 60
541–63.7 years
Shahabuddin et al. (present study) 1997–2007 Hospital: 7.3% 80
82 patients 63.3years
*Modified and reproduced with permission from Noyez L, van Eck FM. Long term cardiac survival after reoperative coronary artery bypass grafting. Eur J Cardiothorac Surg
2004 25: 59-64. †Weintraub [I], total study; Weintraub [II], only patients between 60 and 69 years old.
Figure: Survival curve.
of more than 80% (Figure-2). 
Discussion
Coronary artery disease is known to progress in
both grafted and non grafted vessels and often necessitates
reoperation. The annual incidence of reoperation, which
increases with the length of follow-up, is 1.1% at 5 years
and 3.2% at 10 years.1 It has been estimated that 10-20%
of all patients who have had CABG will require a second
bypass procedure within 10 years. Coronary re-operations
are demanding procedures especially with an increased
risk profile of these patients. They have advanced disease
and are poor surgical candidates in view of old age, more
co morbid factors, decreased left ventricle Ejection
Fraction and more extensive arteriopathy.2 It is also
important to select patients with impaired left ventricular
function to achieve objective of redo CABG7 Coronary
artery disease (CAD) progresses with time involving
native vessels, (both grafted and non-grafted), and the
grafted veins.3 This study highlights the very important
aspect of progression of coronary artery disease
subsequent to surgical repair. In the developing world redo
CABG is considered a high risk operation with only a few
centers offering treatment to such patients. Our series is
among the few experiences being reported from
developing countries.8,9 Such challenging operations
should be undertaken in experienced tertiary care centers
to have internationally comparable results.
The technical challenges associated with redo
CABG are multiple. Sternal re-entry can result in damage to
the right ventricle (RV), aorta or previous grafts. The use of
an oscillating saw and a preoperative chest X-ray to judge
the distance between the posterior sternal surface and the
anterior surface of the right ventricle helps to minimize
these risk.10 Secondly there is an issue of availability of
conduits, more so with second time redo. Thirdly, the
handling of patent but diseased grafts can result in
embolisation of debri and perioperative MI.6 Fourth and the
most important aspect was myocardial protection. It might
be difficult in these cases to obtain desirable myocardial
protection via antegrade route alone. Retrograde
cardioplegia is reported to decrease hospital mortality.11
Hence we used a combination of antegrade and retrograde
route along with direct graft cardioplegia to enhance
myocardial protection. 
This study is a descriptive case series. Therefore, a
multivariate analysis could not be performed to determine
risk factors for redo CABG. Nevertheless, on reviewing the
data, certain possible predictors for reoperation can be
identified. These include left ventricular function and non-
harvesting of the IMA.
Only eighty two patients who underwent redo
CABG on CPB over a decade were included which may be
the result of the referral pattern for redo CABG. This is
because of the awareness about the increased mortality
associated with redo CABG and the cost of surgery.
Literature search has revealed limited reports of redo
CABG on CPB from developing countries. The annual
incidence of reoperation, which increases with the length of
follow-up, is 1.1% at 5 years and 3.2% at 10 years.1
Majority of patients undergoing reoperation was more than
10 years of the primary surgery reinforcing the fact that
atherosclerosis is an ongoing process. 
We looked into the impact of surgery on improving
their functional status and survival on follow up and early
postoperative mortality. Six patients died in the hospital
postoperatively. Redo CABG is a major surgical
procedure and carries a higher mortality than primary
CABG.4 The best results have been reported from the
Cleveland Clinic with an operative mortality for
reoperative CABG of 3.4%.12 Even in patients undergoing
redo CABG before 45 years of age the mortality is 4.4%.9
However those who survived have shown a remarkable
improvement in their functional status and majority of the
patients were in functional class I, satisfying one of the
important objective of redo CABG. The hospital survivors
were followed for a median period of 3.5 years after
hospital discharge. It was satisfying to see the five year
survival is comparable to international literature.13 It was
also noticed that six percent of the patients died during
their follow up period supporting literature that patients
requiring redo CABG tend to have different disease
severity as compared to patients requiring primary CABG
during their subsequent years.14
There are certain limitations of this study like
retrospective nature with its inherent issues, however
after careful search it was found to be the first study from
our country looking at the redo CABG with their
outcomes in terms of survival and functional class. The
mortality appears to be on the higher side of the range as
it is crude mortality and people in this part of the world
seek medical attention late which translates into adverse
outcome. If we look at the review of survival and
mortality by Noyez et al from various groups it is evident
that we have comparable results in terms of mortality and
5 year survival (Table-2).13,15-21 The other limitation with
our study was that a small subset of patients were lost to
follow up.
Conclusion
In conclusion, redo CABG is technically a
challenging procedure requiring experience to manage these
patients. The aim should be to achieve desired level of
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revascularization without damaging the myocardium. A
high level of surgical expertise and supporting services are
required to safely perform Redo CABG with acceptable
morbidity and mortality and achieve good functional
outcome. 
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